Skip to main content
Top
Published in: Endocrine Pathology 3/2017

01-09-2017

Novel Cause of ‘Black Thyroid’: Intraoperative Use of Indocyanine Green

Authors: Rebecca D. Chernock, Ryan S. Jackson

Published in: Endocrine Pathology | Issue 3/2017

Login to get access

Abstract

The antibiotic minocycline is virtually pathognomonic for brown-black discoloration of the thyroid gland referred to as ‘black thyroid’. Black thyroid’ is an incidental finding in patients taking the drug who undergo thyroid surgery for another indication and is not of known clinical significance. However, its recognition is important so as not to raise concern for a disease process. Here, we present the first case of ‘black thyroid’ attributable to the iodine-containing compound indocyanine green. Intraoperative indocyanine green was administered as part of a research protocol transoral robotic-assisted surgery for a base of tongue cancer in a 44-year-old man. Hemithyroidectomy was subsequently performed during the same operation for further evaluation of an indeterminate thyroid nodule. The resected thyroid lobe was dark, nearly black in color, and histologically showed extensive brown pigment deposition in the follicular epithelial cells and colloid, mimicking minocycline-induced ‘black thyroid’. In this case, however, the patient was not taking minocycline; instead the ‘black thyroid’ was attributed to the iodine-containing compound indocyanine green. Indocyanine green is a hereto unreported cause of ‘black thyroid’ with histopathologic features that are remarkably similar to that induced by minocycline. Indocyanine green should be included the differential diagnosis of ‘black thyroid’. Clinical history is important so as not to raise concern for a disease process.
Literature
1.
go back to reference Sethi R, Kozin E, Lin HW, Faquin WC, Randolph GW (2012) Pathology quiz case 2. Diagnosis: papillary thyroid carcinoma arising in the setting of black thyroid. Arch Otolaryngol Head Neck Surg. 138:1093–1095.CrossRefPubMed Sethi R, Kozin E, Lin HW, Faquin WC, Randolph GW (2012) Pathology quiz case 2. Diagnosis: papillary thyroid carcinoma arising in the setting of black thyroid. Arch Otolaryngol Head Neck Surg. 138:1093–1095.CrossRefPubMed
3.
go back to reference Bruins NA, Oswald JE, Morreau H, Kievit J, Pavel S, Smelt AHM (2007) Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. Neth J Med 65:185–187.PubMed Bruins NA, Oswald JE, Morreau H, Kievit J, Pavel S, Smelt AHM (2007) Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. Neth J Med 65:185–187.PubMed
4.
go back to reference Tacon L, Tan CTK, Alvarado R, Gill AJ, Sywak M, Fulcher G (2008) Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland. Thyroid Off J Am Thyroid Assoc 18:795–797.CrossRef Tacon L, Tan CTK, Alvarado R, Gill AJ, Sywak M, Fulcher G (2008) Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland. Thyroid Off J Am Thyroid Assoc 18:795–797.CrossRef
6.
go back to reference Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, Venermo M, Välisuo P (2012) A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012:940585.CrossRefPubMedPubMedCentral Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, Venermo M, Välisuo P (2012) A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012:940585.CrossRefPubMedPubMedCentral
7.
go back to reference Suh YJ, Choi JY, Chai YJ, Kwon H, Woo J-W, Kim S-J, Kim KH, Lee KE, Lim YT, Youn Y-K (2015) Indocyanine green as a near-infrared fluorescent agent for identifying parathyroid glands during thyroid surgery in dogs. Surg Endosc 29:2811–2817.CrossRefPubMed Suh YJ, Choi JY, Chai YJ, Kwon H, Woo J-W, Kim S-J, Kim KH, Lee KE, Lim YT, Youn Y-K (2015) Indocyanine green as a near-infrared fluorescent agent for identifying parathyroid glands during thyroid surgery in dogs. Surg Endosc 29:2811–2817.CrossRefPubMed
8.
go back to reference Zaidi N, Bucak E, Okoh A, Yazici P, Yigitbas H, Berber E (2016) The utility of indocyanine green near infrared fluorescent imaging in the identification of parathyroid glands during surgery for primary hyperparathyroidism. J Surg Oncol 113:771–774.CrossRefPubMed Zaidi N, Bucak E, Okoh A, Yazici P, Yigitbas H, Berber E (2016) The utility of indocyanine green near infrared fluorescent imaging in the identification of parathyroid glands during surgery for primary hyperparathyroidism. J Surg Oncol 113:771–774.CrossRefPubMed
10.
go back to reference Dumlao JS, Brooks MH, Krauss MT, Bronsky D, Waldstein SS (1970) Suppression of thyroidal iodine uptake after indocyanine green. J Clin Endocrinol Metab 30:531–532.CrossRefPubMed Dumlao JS, Brooks MH, Krauss MT, Bronsky D, Waldstein SS (1970) Suppression of thyroidal iodine uptake after indocyanine green. J Clin Endocrinol Metab 30:531–532.CrossRefPubMed
Metadata
Title
Novel Cause of ‘Black Thyroid’: Intraoperative Use of Indocyanine Green
Authors
Rebecca D. Chernock
Ryan S. Jackson
Publication date
01-09-2017
Publisher
Springer US
Published in
Endocrine Pathology / Issue 3/2017
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9458-z

Other articles of this Issue 3/2017

Endocrine Pathology 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.